Press Releases
Center for Breakthrough Medicines, Nucleus Biologics, and Stoic Bio Announce Strategic Collaboration for Steady Supply of Quality Controlled Cell Culture Media to Expedite Development of Cell and Gene Therapies
San Diego, CA, March 7, 2023 – In a joint effort to accelerate high-quality therapies to market, Nucleus Biologics, The Cell Performance Company™, a leading provider of custom cell culture media solutions for the cell and gene therapy industry, and Stoic Bio, a...
Nucleus Biologics Unveils Expanded Facility in San Diego, New Cleanrooms to Support Cell Culture Media Manufacturing
(San Diego, CA – September 23, 2022) — Nucleus Biologics, The Cell Performance Company™, an industry-leading provider of small lot custom cell culture media, celebrated the opening of its newest building on their San Diego campus and the unveiling of additional...
Nucleus Biologics Obtains ISO 13485:2016 Certification
ISO 13485:2016 certification demonstrates Nucleus Biologics’ commitment to maintaining premium quality standards. (San Diego, CA – August 23, 2022) Nucleus Biologics, The Cell Performance Company™, the industry-leading provider of small lot custom media for the cell...
Nucleus Biologics Announces Krakatoa™, Aiming to Reinvent the Cell Culture Media Industry
Krakatoa’s point of use media manufacturing reduces greenhouse gas emissions by 65% per unit of media produced. (San Diego, CA – February 28, 2022) Nucleus Biologics, The Cell Performance Company™, is proud to announce the launch of Krakatoa™, an innovative,...
Nucleus Biologics Launches Artificial Intelligence Research (NB-AIR): The World’s First AI Platform for Media Configuration That Gives Control Back To The Scientists
For immediate release Nucleus Biologics Launches Artificial Intelligence Research (NB-AIR): The World's First AI Platform for Media Configuration That Gives Control Back To The Scientists SAN DIEGO, Feb. 9, 2021 /PRNewswire/ -- Nucleus Biologics™, The Cell Performance...
Cognate BioServices and Nucleus Biologics announce partnership in Cell and Gene Therapies
For immediate release Cognate BioServices and Nucleus Biologics announce partnership in Cell and Gene Therapies MEMPHIS, Tenn., Jan. 27, 2021 /PRNewswire/ -- Cognate BioServices, Inc., the premier commercial-ready global CDMO in the Cell and Gene Therapy industry, and...
Nucleus Biologics Unveils World’s First Online Portal for Instantaneous Custom cGMP Cell Culture Media Configuration
SAN DIEGO, May 27, 2020 -- Nucleus Biologics, a leader in precision cell culture, today announced the availability of NB-Lux™, an online configuration and ordering platform for cell culture media. Designed for developers of cell therapies, NB-Lux™ speeds formulation...
Nucleus Biologics Develops cGMP CMRL Media and zIF™ Xeno-Free Supplement for Robust Human Islet Cell Culture
SAN DIEGO – February 18, 2020 – Nucleus Biologics™, a leader in precision cell culture, announced today a complete line of cGMP grade media and a new supplement to enable improved insulin response and standardized processing of human pancreatic islets and beta cells....
Nucleus Biologics™ acquires Primorigen Biosciences, gains proprietary, high yield, recombinant protein platform
Nucleus Biologics™ now has the leading xeno-free, recombinant, extracellular matrix SAN DIEGO – August 6, 2019 – Nucleus Biologics™, a leader in precision cell culture, is pleased to announce the acquisition of Primorigen Biosciences, Inc. The addition...
Press Release: Nucleus Biologics Announces Growth, Expansion to New Office
For immediate release Nucleus Biologics Joins Cell Manufacturing Research Initiative SAN DIEGO – SEPTEMBER 20, 2018 – Nucleus Biologics is pleased to announce it has joined the new NSF Engineering Research Center for Cell Manufacturing Technologies, known as CMaT. The...